We are live on ! Find out more
VM

VV Manager Portfolio holdings

AUM $114M
1-Year Est. Return 59.16%
This Fund
S&P 500
This Quarter Est. Return
-8.52%
1 Year Est. Return
+59.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$184M
AUM Growth
-$70.4M
Cap. Flow
-$50.1M
Cap. Flow %
-27.15%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ALLO icon
Allogene Therapeutics
ALLO
+$50.1M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALLO icon
1
Allogene Therapeutics
ALLO
$618M
$158M 85.68%
5,884,326
-1,796,807
-23% -$50.1M
QTTB icon
2
Q32 Bio
QTTB
$346M
$15.1M 8.18%
42,825
STRO icon
3
Sutro Biopharma
STRO
$391M
$11.3M 6.14%
99,558

Similar funds

VV Manager's Q2 2019 Portfolio in Review

As of Q2 2019, VV Manager held 3 positions worth $184M, down 28% from $255M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

VV Manager withdrew a net $50.1M in Q2 2019, reducing 1 holding. Its largest reduction was Allogene Therapeutics, cutting an estimated $50.1M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • VV Manager's biggest Q2 2019 reduction was Allogene Therapeutics, cutting an estimated $50.1M.
  • VV Manager's ten largest holdings make up 100% of its $184M portfolio in Q2 2019.
  • VV Manager opened 0 new positions and closed 0 in Q2 2019.
  • VV Manager's portfolio value fell 28% quarter-over-quarter to $184M.

Based on VV Manager's 13F filing for Q2 2019, filed 10 Jul 2019.